Tuesday 2 March 2021
-
- Standard presentation
A brief history
Arthur S Slutsky (Toronto, Canada)
-
- Standard presentation
What we learned from animal models
John J Marini (St Paul, United States)
-
- Standard presentation
Should any patient die of ARDS?
Jean-Louis Vincent (Brussels, Belgium)
-
- Standard presentation
Are we ready for phenotypes?
Carolyn S Calfee (San Francisco, United States)
-
- Standard presentation
Is COVID-19 similar to “usual” ARDS?
Audrey De Jong (Montpellier, France)
-
- Standard presentation
ARDS in the immunocompromised patient
Virginie Lemiale (Paris, France)
-
- Standard presentation
Pulmonary infections complicating ARDS
Lila Bouadma (Paris, France)
-
- Standard presentation
Ongoing and future clinical trials
Niall Ferguson (Toronto, Canada)
-
- Standard presentation
The role of high flow oxygen
Jens Braunlich (Leipzig, Germany)
-
- Standard presentation
A tidal volume of 6 ml/kg for everybody?
Lise Piquilloud (Lausanne, Switzerland)
-
- Standard presentation
How to ventilate those with brain injury
Chiara Robba (Genoa, Italy)
-
- Standard presentation
How to ventilate obese patients
Samir Jaber (Montpellier, France)
-
- Standard presentation
PO2 and PCO2 targets
Rinaldo Bellomo (Melbourne, Australia)
-
- Standard presentation
Routine recruitment?
Tommaso Mauri (Milan, Italy)
-
- Standard presentation
How to optimize PEEP
Carmen Barbas (Sao Paulo, Brazil)
-
- Standard presentation
The role of esophageal pressure
Daniel Talmor (Boston, United States)
-
- Standard presentation
How technology can assist ventilation
Laurent Brochard (Toronto, Canada)
Future treatments
-
- Round table
Future treatments
Laurent Brochard (Toronto, Canada)
John J Marini (St Paul, United States)
Arthur S Slutsky (Toronto, Canada)
-
- Standard presentation
How chest CT-scan can orient therapy
Davide Chiumello (Milan, Italy)
-
- Standard presentation
VILI and p-SILI
Ewan Goligher (Toronto, Canada)
-
- Standard presentation
The potential role of EELV (FRC) measurement within an advanced monitoring toolkit
-
- Standard presentation
When and how to use prone positioning
V Marco Ranieri (Bologna, Italy)
-
- Standard presentation
When and how to wean the ventilator
Jordi Mancebo (Barcelona, Spain)
-
- Standard presentation
Should we routinely use non-invasive ventilation after weaning?
Sharon Einav (Jerusalem, Israel)
-
- Standard presentation
When and how to use ECMO
Daniel Brodie (New York, United States)
-
- Standard presentation
Are indications for ECCO2R moving from specific diseases to VILI prevention
Eddy Fan (Toronto, Canada)
-
- Standard presentation
When and how to give fluids
Xavier Monnet (Le Kremlin-Bicêtre, France)
-
- Standard presentation
Transfusion strategies
Nicole Juffermans (Amsterdam, Netherlands)
-
- Standard presentation
Hemodynamic monitoring
Antoine Vieillard–Baron (Boulogne-Billancourt, France)
-
- Standard presentation
When and how to use sedative agents
Gerald Chanques (Montpellier, France)
-
- Standard presentation
Inhaled sedation: When, how and why?
Matthieu Jabaudon (Clermont-Ferrand, France)
-
- Standard presentation
When and how to use myorelaxants
Laurent Papazian (Marseille, France)
-
- Standard presentation
When and how to use corticosteroids
Jesus Villar (Las Palmas de Gran Canaria, Spain)
-
- Standard presentation
Emerging pharmacological therapies
John Laffey (Galway, Ireland)
Optimizing lung mechanics
-
- Meet the experts
Optimizing lung mechanics
Niall Ferguson (Toronto, Canada)
Laurent Papazian (Marseille, France)
Daniel Talmor (Boston, United States)
When and how to wean from mechanical ventilation
-
- Meet the experts
When and how to wean from mechanical ventilation
Ewan Goligher (Toronto, Canada)
Nicole Juffermans (Amsterdam, Netherlands)
Jordi Mancebo (Barcelona, Spain)
Supported by unrestricted educational grants from
Baxter SAS
Masimo
GE Healthcare
Sedana Medical
